タクソルの二相合成
Yuzuru Kanda1, Hugh Nakamura1, Shigenobu Umemiya1
1Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Journal of the American Chemical Society
|May 15, 2020
まとめ
研究者はパクリタキセル (Taxol) を生産するための新しい合成アプローチを開発しました. この方法は,天然のテルペン生物合成にインスパイアされ,既存の供給方法を補完して,タクソルの合成のための新しい経路を提供します.
科学分野:
- 自然製品化学
- 有機合成
- 薬剤化学
背景:
- パクリタキセル (Taxol) は,天然の源から得られた非常に効果的な抗がん剤です.
- パクリタクセルの初期供給の懸念は,その全合成に関する広範な研究を促した.
- 現在のパクリタキセルの生産は,植物由来または生物合成で生産された材料に依存しています.
研究 の 目的:
- パクリタキセル (Taxol) の生産のための新しい合成戦略を探求する.
- 自然の生体合成経路に触発された 異なる合成アプローチを開発する
- 合成パクリタキセルへのアクセスの代替方法を提案する.
主な方法:
- 補完的な合成戦略が考案された.
- このアプローチは,テルペンの生物合成装置から整体的にモデル化されました.
- パクリタキセルへの合成経路が開発された.
主要な成果:
- パクリタキセルの新しい合成アプローチの実現可能性を示した.
- 合成戦略は,テルペンの合成のための天然の生合成プロセスを模倣する.
- この方法は,合成パクリタキセルへの新しい経路を提供します.
結論:
- パクリタキセル (Taxol) の合成には新しい合成方法が用いられる.
- この方法は,既存の自然と生物合成の供給戦略を補完しています.
- この発見は複雑な天然製品の合成に 新たな道を開きます
関連する概念動画
Drugs that Stabilize Microtubules
2.5K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Preparation of Diols and Pinacol Rearrangement
4.0K
Compounds bearing two hydroxyl groups are known as diols. When the hydroxyl groups are located on adjacent carbon atoms, the diols are called vicinal diols or glycols. Under acidic conditions, vicinal diols undergo a specific reaction called pinacol rearrangement.
The reaction begins with transferring a proton from the acid catalyst to one of the hydroxyl groups, producing an oxonium ion.
The reaction begins with transferring a proton from the acid catalyst to one of the hydroxyl groups, producing an oxonium ion.
4.0K
Phase II Conjugation Reactions: Overview
654
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
654
Phase II Reactions: Miscellaneous Conjugation Reactions
284
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
284


